QT
INDV icon

Quantbot Technologies’s Indivior Pharmaceuticals INDV Stock Holding History

Quantbot Technologies’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Sell
35,830
-9,089
-20% -$330K 0.06% 477
2026
Q1 		$1.37M Sell
44,919
-118,960
-73% -$3.93M 0.06% 492
2025
Q4 		$5.88M Buy
163,879
+36,642
+29% +$1.12M 0.2% 134
2025
Q3 		$3.07M Buy
+127,237
New +$2.66M 0.08% 377

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantbot Technologies's INDV Position: Q2 2026 in Review

Quantbot Technologies reduced its Indivior Pharmaceuticals (INDV) stake by 20% in Q2 2026, selling an estimated $330K and leaving 35,830 shares worth $1.47M. The position accounts for 0.06% of the portfolio, ranked #477.

Quantbot Technologies first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.88M in Q4 2025. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Quantbot Technologies held 35,830 shares of Indivior Pharmaceuticals worth $1.47M as of Q2 2026.
  • Quantbot Technologies sold 9,089 Indivior Pharmaceuticals shares in Q2 2026, an estimated $330K.
  • Indivior Pharmaceuticals made up 0.06% of Quantbot Technologies's portfolio in Q2 2026, its #477 holding.
  • Quantbot Technologies first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Quantbot Technologies's Indivior Pharmaceuticals position peaked at $5.88M in Q4 2025.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.